These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 10089857)

  • 21. The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study.
    Auricchio A; Stellbrink C; Sack S; Block M; Vogt J; Bakker P; Mortensen P; Klein H
    Am J Cardiol; 1999 Mar; 83(5B):130D-135D. PubMed ID: 10089855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction.
    Aronow WS
    Geriatrics; 2005 Feb; 60(2):24, 26-8. PubMed ID: 15742919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular pacing in patients with heart failure: evaluation study with Fourier analysis of radionuclide ventriculography.
    Santomauro M; Pace L; Duilio C; Ottaviano L; Borrelli A; Ferro A; Monteforte N; Cuocolo A; Salvatore M; Chiariello M
    Ital Heart J; 2004 Dec; 5(12):906-11. PubMed ID: 15706995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials.
    Friedman DJ; Al-Khatib SM; Zeitler EP; Han J; Bardy GH; Poole JE; Bigger JT; Buxton AE; Moss AJ; Lee KL; Steinman R; Dorian P; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Inoue LYT; Sanders GD
    Am Heart J; 2017 Sep; 191():21-29. PubMed ID: 28888266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
    Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term effects and mortality of biventricular pacing therapy in patients with congestive heart failure].
    Wang DM; Han YL; Zang HY; Zhou WW; Jing QM; Wang ZL; Wang SL; Li F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Aug; 33(8):717-9. PubMed ID: 16188059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which patients with congestive heart failure may benefit from biventricular pacing?
    Galizio NO; Pesce R; Valero E; Gonzalez JL; Favaloro RR; Favaloro L; Perrone S; Davila P; Godoy M
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):158-61. PubMed ID: 12687804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biventricular pacing in patients with ICD: how many patients are possible candidates?
    Werling C; Weisse U; Siemon G; Kiessling AH; Rameken M; Schwacke H; Saggau W; Senges J; Seidl K
    Thorac Cardiovasc Surg; 2002 Apr; 50(2):67-70. PubMed ID: 11981703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should stimulation therapy for congestive heart failure be combined with defibrillation backup?
    Gaita F; Bocchiardo M; Porciani MC; Vivalda L; Colella A; Di Donna P; Caponi D; Bruzzone M; Padeletti L
    Am J Cardiol; 2000 Nov; 86(9A):165K-158K. PubMed ID: 11084118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy.
    Ruwald MH; Mittal S; Ruwald AC; Aktas MK; Daubert JP; McNitt S; Al-Ahmad A; Jons C; Kutyifa V; Steinberg JS; Wang P; Moss AJ; Zareba W
    J Am Coll Cardiol; 2014 Sep; 64(10):971-81. PubMed ID: 25190230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Congestive heart failure and arrhythmia].
    Kasanuki H
    Nihon Rinsho; 1993 May; 51(5):1354-61. PubMed ID: 8101240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biventricular pacing for atrioventricular block and systolic dysfunction.
    Curtis AB; Worley SJ; Adamson PB; Chung ES; Niazi I; Sherfesee L; Shinn T; Sutton MS;
    N Engl J Med; 2013 Apr; 368(17):1585-93. PubMed ID: 23614585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
    Baravelli M; Salerno-Uriarte D; Guzzetti D; Rossi MC; Zoli L; Forzani T; Salerno-Uriarte JA
    Int J Cardiol; 2005 Oct; 105(1):53-7. PubMed ID: 16207545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Survival With Implantable Cardioverter-Defibrillator in Different Symptomatic Functional Classes of Heart Failure.
    Biton Y; Rosero S; Moss A; Zareba W; Kutyifa V; Baman J; Barsheshet A; McNitt S; Polonsky B; Goldenberg I
    Am J Cardiol; 2018 Mar; 121(5):615-620. PubMed ID: 29307459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiac resynchronization therapy in terminal heart failure: current status and prospects].
    Sack S; Heinzel F; Dagres N; Wieneke H; Erbel R
    Herz; 2001 Feb; 26(1):84-8. PubMed ID: 11258115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.